Ann F Chambers Selected Research

Erlotinib Hydrochloride (CP 358,774)

1/2018

Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann F Chambers Research Topics

Disease

62	Neoplasms (Cancer) 01/2020 - 04/2002
44	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2002
40	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2002
9	Carcinoma (Carcinomatosis) 01/2020 - 08/2002
7	Brain Neoplasms (Brain Tumor) 06/2018 - 01/2007
6	Lymphatic Metastasis 12/2014 - 06/2006
5	Melanoma (Melanoma, Malignant) 03/2011 - 01/2007
3	Carcinogenesis 01/2020 - 01/2004
3	Colonic Neoplasms (Colon Cancer) 10/2003 - 04/2002
2	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 05/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2016 - 09/2014
2	Ovarian Neoplasms (Ovarian Cancer) 02/2012 - 01/2006
2	Disease Progression 02/2012 - 01/2008
2	Neoplasm Micrometastasis 07/2011 - 10/2003
1	Triple Negative Breast Neoplasms 01/2018
1	Pathologic Complete Response 11/2017
1	Hypoxia (Hypoxemia) 09/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2014
1	Lung Injury 05/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2011
1	Liver Diseases (Liver Disease) 03/2011
1	Experimental Melanoma 01/2009
1	Hemorrhage 01/2009

Drug/Important Bio-Agent (IBA)

33	OsteopontinIBA 01/2020 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2002
12	IntegrinsIBA 12/2014 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2004
6	Biological ProductsIBA 12/2011 - 02/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2005
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2003
4	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2005
4	PhosphoproteinsIBA 01/2020 - 09/2003
4	Tumor Biomarkers (Tumor Markers)IBA 06/2011 - 04/2002
4	Carrier Proteins (Binding Protein)IBA 07/2006 - 04/2002
3	LigandsIBA 01/2018 - 09/2003
3	IronIBA 10/2017 - 01/2007
3	Pharmaceutical PreparationsIBA 06/2016 - 07/2009
3	Messenger RNA (mRNA)IBA 08/2008 - 01/2005
2	Estrogen ReceptorsIBA 01/2018 - 01/2007
2	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 12/2014
2	Hormones (Hormone)IBA 01/2014 - 08/2002
2	Glycoproteins (Glycoprotein)IBA 01/2014 - 01/2008
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2012 - 08/2011
2	SERPIN-B5 (maspin)IBA 02/2012 - 08/2011
2	ferric oxide (iron oxide)IBA 07/2011 - 11/2009
2	Small Interfering RNA (siRNA)IBA 07/2011 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2009 - 12/2003
2	Indicators and Reagents (Reagents)IBA 05/2009 - 05/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2009 - 11/2007
2	GenisteinIBA 01/2009 - 04/2005
2	Cell Surface ReceptorsIBA 11/2007 - 01/2005
2	OligonucleotidesIBA 08/2005 - 04/2002
1	Thymine DNA GlycosylaseIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	matrigelIBA 01/2016
1	GasotransmittersIBA 09/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2015
1	TenascinIBA 12/2014
1	Cyclin A2IBA 12/2014
1	Antisense OligonucleotidesIBA 12/2014
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2014
1	CortactinIBA 09/2014
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2014
1	Tamoxifen FDA LinkGeneric 01/2014
1	neuropeptide Y5 receptorIBA 07/2012
1	Neuropeptide YIBA 07/2012
1	SerpinsIBA 02/2012
1	Cadherins (E-Cadherin)IBA 01/2012
1	Vascular Endothelial Growth Factor CIBA 01/2012
1	Vascular Endothelial Growth Factor DIBA 01/2012
1	JSM6427IBA 12/2011
1	volociximabIBA 12/2011
1	AntibodiesIBA 12/2011
1	acetyl- prolyl- histidyl- seryl- cysteinyl- asparaginamideIBA 12/2011
1	Gadolinium DTPA (Magnevist)FDA Link 11/2011
1	src-Family KinasesIBA 10/2011
1	Nuclear Export Signals (Nuclear Export Signal)IBA 08/2011
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 03/2011
1	imidazoleIBA 03/2011
1	TriterpenesIBA 03/2011
1	bardoxoloneIBA 03/2011
1	Aprotinin (Trasylol)FDA Link 01/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2009
1	Fibrinolysin FDA Link 01/2009
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2009

Therapy/Procedure

23	Therapeutics 01/2018 - 08/2002
5	Radiotherapy 06/2018 - 08/2002
3	Aftercare (After-Treatment) 06/2018 - 04/2002
3	Neoadjuvant Therapy 11/2017 - 05/2014
3	Drug Therapy (Chemotherapy) 11/2017 - 12/2003
2	Castration 02/2016 - 05/2009
2	Injections 01/2008 - 04/2002
1	Cranial Irradiation 10/2017
1	Prostatectomy (Retropubic Prostatectomy) 02/2016
1	Heterologous Transplantation (Xenotransplantation) 12/2014
1	Oral Administration 03/2011
1	Immunotherapy 01/2009